Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antifungal combinations against simulated Candida albicans endocardial vegetations.

Literature DB >> 19307372

Antifungal combinations against simulated Candida albicans endocardial vegetations.

Abstract

The in vitro effects of flucytosine (5FC), liposomal amphotericin B (L-AmB), and micafungin (Mica) combinations against two Candida albicans strains that simulated 24-hour-old endocardial vegetations were studied. Mica was superior to 5FC or L-AmB, and the 5FC-L-AmB-Mica combination was superior to all other treatments for one strain but no different from the dual combination of L-AmB-Mica for the other strain.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19307372 PMCID： PMC2687236 DOI： 10.1128/AAC.01026-08

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

15 in total

Review 1. Candida biofilm resistance.

Authors: Pranab K Mukherjee; Jyotsna Chandra
Journal: Drug Resist Updat Date: 2004 Aug-Oct Impact factor: 18.500

Review 2. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents.

Authors: Christophe d'Enfert
Journal: Curr Drug Targets Date: 2006-04 Impact factor: 3.465

3. In vitro activity of anidulafungin against Candida albicans biofilms.

Authors: Melissa J Jacobson; Kerryl E Piper; Gary Nguyen; James M Steckelberg; Robin Patel
Journal: Antimicrob Agents Chemother Date: 2008-04-07 Impact factor: 5.191

Review 4. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors: Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal: Circulation Date: 2006-08-01 Impact factor: 29.690

5. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors: Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal: Antimicrob Agents Chemother Date: 2002-11 Impact factor: 5.191

6. In vitro activity of caspofungin against Candida albicans biofilms.

Authors: Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal: Antimicrob Agents Chemother Date: 2002-11 Impact factor: 5.191

Review 7. Fungal endocarditis: evidence in the world literature, 1965-1995.

Authors: M E Ellis; H Al-Abdely; A Sandridge; W Greer; W Ventura
Journal: Clin Infect Dis Date: 2000-12-12 Impact factor: 9.079

8. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors: D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal: Antimicrob Agents Chemother Date: 2002-06 Impact factor: 5.191

9. Candida infective endocarditis.

Authors: J W Baddley; D K Benjamin; M Patel; J Miró; E Athan; B Barsic; E Bouza; L Clara; T Elliott; Z Kanafani; J Klein; S Lerakis; D Levine; D Spelman; E Rubinstein; P Tornos; A J Morris; P Pappas; V G Fowler; V H Chu; C Cabell
Journal: Eur J Clin Microbiol Infect Dis Date: 2008-02-19 Impact factor: 3.267

Antifungal combinations against simulated Candida albicans endocardial vegetations.

Review 1. Candida biofilm resistance.

Review 2. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents.

3. In vitro activity of anidulafungin against Candida albicans biofilms.

5. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

6. In vitro activity of caspofungin against Candida albicans biofilms.

Review 7. Fungal endocarditis: evidence in the world literature, 1965-1995.

8. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

9. Candida infective endocarditis.

10. Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.

Review 1. Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature.

2. Candida parapsilosis endocarditis. Report of cases and review of the literature.

3. Isolated pulmonary valve infective endocarditis in a middle aged man caused by Candida albicans: a case report.